Correlation Between PDS Biotechnology and ADC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and ADC Therapeutics SA, you can compare the effects of market volatilities on PDS Biotechnology and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and ADC Therapeutics.

Diversification Opportunities for PDS Biotechnology and ADC Therapeutics

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between PDS and ADC is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and ADC Therapeutics go up and down completely randomly.

Pair Corralation between PDS Biotechnology and ADC Therapeutics

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 1.31 times more return on investment than ADC Therapeutics. However, PDS Biotechnology is 1.31 times more volatile than ADC Therapeutics SA. It trades about -0.24 of its potential returns per unit of risk. ADC Therapeutics SA is currently generating about -0.41 per unit of risk. If you would invest  312.00  in PDS Biotechnology Corp on August 24, 2024 and sell it today you would lose (92.00) from holding PDS Biotechnology Corp or give up 29.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  ADC Therapeutics SA

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
ADC Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ADC Therapeutics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

PDS Biotechnology and ADC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and ADC Therapeutics

The main advantage of trading using opposite PDS Biotechnology and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.
The idea behind PDS Biotechnology Corp and ADC Therapeutics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device